| SC 13G | 2023-01-03 | CITADEL ADVISORS LLC | Protagonist Therapeutics, Inc | - | 3.6% | EDGAR |
| SC 13G/A | 2022-12-12 | FMR LLC | Protagonist Therapeutics, Inc | 385,863 | 0.8% | EDGAR |
| SC 13G/A | 2022-07-11 | STATE STREET CORP | Protagonist Therapeutics, Inc | - | 13.9% | EDGAR |
| SC 13G/A | 2022-06-10 | FMR LLC | Protagonist Therapeutics, Inc | 3,554,095 | 7.3% | EDGAR |
| SC 13G/A | 2022-02-14 | Point72 Asset Management, L.P. | Protagonist Therapeutics, Inc | 2,419,763 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-14 | RTW INVESTMENTS, LP | Protagonist Therapeutics, Inc | 2,599,822 | 5.4% | EDGAR |
| SC 13G/A | 2022-02-14 | BIOTECHNOLOGY VALUE FUND L P | Protagonist Therapeutics, Inc | 2,638,998 | 5.5% | EDGAR |
| SC 13G/A | 2022-02-14 | Consonance Capital Management LP | Protagonist Therapeutics, Inc | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-11 | FARALLON CAPITAL MANAGEMENT LLC | Protagonist Therapeutics, Inc | 387,051 | 0.8% | EDGAR |
| SC 13G | 2022-02-10 | STATE STREET CORP | Protagonist Therapeutics, Inc | - | 5.4% | EDGAR |
| SC 13G/A | 2022-02-09 | FMR LLC | Protagonist Therapeutics, Inc | 6,847,277 | 14.3% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | Protagonist Therapeutics, Inc | 3,281,636 | 6.9% | EDGAR |
| SC 13G | 2021-09-21 | Point72 Asset Management, L.P. | Protagonist Therapeutics, Inc | 4,312,300 | 9.1% | EDGAR |
| SC 13G | 2021-02-17 | Consonance Capital Management LP | Protagonist Therapeutics, Inc | 2,461,277 | 5.8% | EDGAR |
| SC 13G/A | 2021-02-16 | BIOTECHNOLOGY VALUE FUND L P | Protagonist Therapeutics, Inc | 2,311,108 | 5.4% | EDGAR |
| SC 13G/A | 2021-02-16 | FARALLON CAPITAL MANAGEMENT LLC | Protagonist Therapeutics, Inc | 687,600 | 1.6% | EDGAR |
| SC 13G | 2021-02-16 | Consonance Capital Management LP | Protagonist Therapeutics, Inc | 2,461,277 | 5.8% | EDGAR |
| SC 13G/A | 2021-02-12 | RTW INVESTMENTS, LP | Protagonist Therapeutics, Inc | 3,650,069 | 8.7% | EDGAR |
| SC 13G/A | 2021-02-11 | ADAGE CAPITAL PARTNERS GP, L.L.C. | Protagonist Therapeutics, Inc | 1,150,045 | 2.7% | EDGAR |
| SC 13G/A | 2021-02-08 | FMR LLC | Protagonist Therapeutics, Inc | 6,452,764 | 15.1% | EDGAR |